Literature DB >> 25099703

Impact of expanded criteria variables on outcomes of kidney transplantation from donors after cardiac death.

Pramod Nagaraja1, Gareth W Roberts, Michael Stephens, Szabolcs Horvath, Zsolt Kaposztas, Rafael Chavez, Argiris Asderakis.   

Abstract

INTRODUCTION: To expand the donor pool, kidney transplants are being performed using donors who were previously considered unacceptable. We applied the United Network for Organ Sharing criteria to define expanded criteria donors (ECD) within the donation after cardiac death (DCD) and donation after brain stem death (DBD) cohorts. We compared outcomes of DCD and DBD transplants with and without (standard criteria donor [SCD]) the ECD criteria.
METHODS: This was a single-center retrospective study of all deceased donor transplants from 2004 to 2010 (n=359). Four groups were identified--DBD-SCD (n=154), DBD-ECD (n=93), DCD-SCD (n=78), and DCD-ECD (n=34). Kaplan-Meier analysis of graft and patient survival and multiple regression analysis of 1-year graft function were performed.
RESULTS: One-year and two-year uncensored graft survivals were similar between DCD-ECD and DCD-SCD cohorts (1 year, 90% and 93%; 2 years, 81% and 93% respectively; log-rank test P=0.2). Median estimated glomerular filtration rate (eGFR) was lower in DCD-ECD recipients at 12 months (41 vs. 53 mL/min, P=0.003) and 24 months (33 vs. 54 mL/min, P<0.001) compared with DCD-SCD recipients. Compared with DBD-ECD recipients also at 24 months, DCD-ECD recipients showed a lower graft function (median, eGFR 33 vs. 47 mL/min; P=0.007) but similar graft survival. Expanded criteria donor status (B=-9.7, P=0.01) was associated with a lower 1-year eGFR within the DCD cohort, with donor age (B=-0.42, P=0.002) being the only significant ECD variable.
CONCLUSION: Short-term graft survival in DCD-ECD transplants was comparable to DCD-SCD and DBD-ECD transplants albeit with poorer allograft function at 2 years. Quality-of-life studies are needed to determine the true value of these transplants, particularly when performed to older recipients.

Entities:  

Mesh:

Year:  2015        PMID: 25099703     DOI: 10.1097/TP.0000000000000304

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Family and transplant professionals' views of organ recovery before circulatory death for imminently dying patients: A qualitative study using semistructured interviews and focus groups.

Authors:  Christopher J Zimmermann; Nathan D Baggett; Lauren J Taylor; Anne Buffington; Joseph Scalea; Norman Fost; Kenneth D Croes; Joshua D Mezrich; Margaret L Schwarze
Journal:  Am J Transplant       Date:  2019-03-14       Impact factor: 8.086

2.  Combining Clinical Parameters and Acute Tubular Injury Grading Is Superior in Predicting the Prognosis of Deceased-Donor Kidney Transplantation: A 7-Year Observational Study.

Authors:  Jiali Wang; Jinqi Liu; Wenrui Wu; Shicong Yang; Longshan Liu; Qian Fu; Jun Li; Xutao Chen; Ronghai Deng; Chenglin Wu; Sizhe Long; Wujun Zhang; Huanxi Zhang; Haiping Mao; Wenfang Chen
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

3.  Improving Donor Conversion Rates at a Level One Trauma Center: Impact of Best Practice Guidelines.

Authors:  Rodrigo F Alban; Bobby L Gibbons; Vanessa L Bershad
Journal:  Cureus       Date:  2016-11-22

4.  Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation.

Authors:  Chen-Guang Ding; Li-Zi Jiao; Feng Han; He-Li Xiang; Pu-Xun Tian; Xiao-Ming Ding; Xiao-Ming Pan; Xiao-Hui Tian; Yang Li; Jin Zheng; Wu-Jun Xue
Journal:  Chin Med J (Engl)       Date:  2018-06-05       Impact factor: 2.628

5.  Single Graft Utilization From Donors With Severe Acute Kidney Injury After Circulatory Death.

Authors:  Yusuke Tomita; Kazuhiro Iwadoh; Yuichi Ogawa; Katsuyuki Miki; Kotaro Kai; Akihito Sannomiya; Toru Murakami; Ichiro Koyama; Kumiko Kitajima; Ichiro Nakajima; Shohei Fuchinoue
Journal:  Transplant Direct       Date:  2018-03-19

6.  A molecular signature for delayed graft function.

Authors:  Dagmara McGuinness; Suhaib Mohammed; Laura Monaghan; Paul A Wilson; David B Kingsmore; Oliver Shapter; Karen S Stevenson; Shana M Coley; Luke Devey; Robert B Kirkpatrick; Paul G Shiels
Journal:  Aging Cell       Date:  2018-08-09       Impact factor: 9.304

7.  Effects of Normothermic Machine Perfusion Conditions on Mesenchymal Stromal Cells.

Authors:  Jesus M Sierra Parraga; Kaithlyn Rozenberg; Marco Eijken; Henri G Leuvenink; James Hunter; Ana Merino; Cyril Moers; Bjarne K Møller; Rutger J Ploeg; Carla C Baan; Bente Jespersen; Martin J Hoogduijn
Journal:  Front Immunol       Date:  2019-04-10       Impact factor: 7.561

8.  Early outcomes of kidney transplantation from elderly donors after circulatory death (GEODAS study).

Authors:  María José Pérez-Sáez; Omar Lafuente Covarrubias; Domingo Hernández; Francesc Moreso; Edoardo Melilli; Javier Juega; Erika de Sousa; Paula López-Sánchez; María Luisa Rodríguez-Ferrero; Naroa Maruri-Kareaga; María Dolores Navarro; Rosalía Valero; María Auxiliadora Mazuecos; Francisco Llamas; Paloma Martín-Moreno; Antón Fernández-García; Jordi Espí; Carlos Jiménez; Ana Ramos; Eva Gavela; Julio Pascual; Jose M Portolés
Journal:  BMC Nephrol       Date:  2019-06-26       Impact factor: 2.388

9.  Kidney transplantation outcomes from elderly donors after circulatory death: a comparison with elderly brain-dead donors.

Authors:  Anna Buxeda; Gonzalo Velis; Carlos Arias-Cabrales; Ana Zapatero; Carla Burballa; Dolores Redondo-Pachón; Marisa Mir; Marta Crespo; Julio Pascual; María José Pérez-Sáez
Journal:  Clin Kidney J       Date:  2020-09-10

10.  Survival benefit of accepting kidneys from older donation after cardiac death donors.

Authors:  Sile Yu; Jane J Long; Yifan Yu; Mary G Bowring; Jennifer D Motter; Tanveen Ishaque; Niraj Desai; Dorry L Segev; Jacqueline M Garonzik-Wang; Allan B Massie
Journal:  Am J Transplant       Date:  2020-09-17       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.